Theravance Biopharma Overview
Theravance Biopharma Target Price
Analysts' 12-month price predictions for TBPH.
Get informed when a big investor buys or sells
+ FollowShare Price
$15.92
Average Target Price
$14.00
12.1% downside
12.1% downside1 analysts in the last 4 months
High: $14 | Low: $14
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-04 | B.Riley FinancialMayank Mamtani | $14 | 12.1% downside |  |
| 2025-12-03 | Oppenheimer | $27 |  69.6% upside | |
| 2025-11-26 | BTIG | $40 | 151.3% upside | |
| 2024-11-13 | Leerink PartnersDavid Risinger | $10 | 37.2% downside | |
| 2024-08-06 | H.C. WainwrightDouglas Tsao | $15 | 5.8% downside | |
| 2024-04-12 | BTIGJulian Harrison | $21 | 31.9% upside | |
| 2022-11-17 | Leerink Partners | $14 | 12.1% downside | |